BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8057297)

  • 1. 5-[(3-nitropyrid-2-yl)amino]indoles: novel serotonin agonists with selectivity for the 5-HT1D receptor. Variation of the C3 substituent on the indole template leads to increased 5-HT1D receptor selectivity.
    Macor JE; Blank DH; Fox CB; Lebel LA; Newman ME; Post RJ; Ryan K; Schmidt AW; Schulz DW; Koe BK
    J Med Chem; 1994 Aug; 37(16):2509-12. PubMed ID: 8057297
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
    J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of 3-[2-(dimethylamino)ethyl]-5-[(1,1-dioxo-5-methyl-1,2,5-thiadiazolidin- 2-yl)-methyl]-1H-indole and analogues: agonists for the 5-HT1D receptor.
    Castro JL; Baker R; Guiblin AR; Hobbs SC; Jenkins MR; Russell MG; Beer MS; Stanton JA; Scholey K; Hargreaves RJ
    J Med Chem; 1994 Sep; 37(19):3023-32. PubMed ID: 7932524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotonin.
    Macor JE; Blake J; Fox CB; Johnson C; Koe BK; Lebel LA; Morrone JM; Ryan K; Schmidt AW; Schulz DW
    J Med Chem; 1992 Nov; 35(23):4503-5. PubMed ID: 1447752
    [No Abstract]   [Full Text] [Related]  

  • 5. 3-(Piperazinylpropyl)indoles: selective, orally bioavailable h5-HT1D receptor agonists as potential antimigraine agents.
    Chambers MS; Street LJ; Goodacre S; Hobbs SC; Hunt P; Jelley RA; Matassa VG; Reeve AJ; Sternfeld F; Beer MS; Stanton JA; Rathbone D; Watt AP; MacLeod AM
    J Med Chem; 1999 Feb; 42(4):691-705. PubMed ID: 10052976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship of 5-chloro-2-methyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole analogues as 5-HT(6) receptor agonists.
    Mattsson C; Svensson P; Boettcher H; Sonesson C
    Eur J Med Chem; 2013 May; 63():578-88. PubMed ID: 23542166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery.
    Longmore J; Maguire JJ; MacLeod A; Street L; Schofield WN; Hill RG
    Br J Clin Pharmacol; 2000 Feb; 49(2):126-31. PubMed ID: 10671906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2a-[4-(Tetrahydropyridoindol-2-yl)butyl]tetrahydrobenzindole derivatives: new selective antagonists of the 5-hydroxytryptamine7 receptor.
    Kikuchi C; Ando T; Watanabe T; Nagaso H; Okuno M; Hiranuma T; Koyama M
    J Med Chem; 2002 May; 45(11):2197-206. PubMed ID: 12014957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Arylsulfonylindole derivatives as serotonin 5-HT(6) receptor ligands.
    Russell MG; Baker RJ; Barden L; Beer MS; Bristow L; Broughton HB; Knowles M; McAllister G; Patel S; Castro JL
    J Med Chem; 2001 Nov; 44(23):3881-95. PubMed ID: 11689074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and serotonergic activity of 5-(oxadiazolyl)tryptamines: potent agonists for 5-HT1D receptors.
    Street LJ; Baker R; Castro JL; Chambers MS; Guiblin AR; Hobbs SC; Matassa VG; Reeve AJ; Beer MS; Middlemiss DN
    J Med Chem; 1993 May; 36(11):1529-38. PubMed ID: 8496922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.
    Russell MG; Matassa VG; Pengilley RR; van Niel MB; Sohal B; Watt AP; Hitzel L; Beer MS; Stanton JA; Broughton HB; Castro JL
    J Med Chem; 1999 Dec; 42(24):4981-5001. PubMed ID: 10585208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist activity of sumatriptan and metergoline at the human 5-HT1D beta receptor: further evidence for a role of the 5-HT1D receptor in the action of sumatriptan.
    Miller KJ; King A; Demchyshyn L; Niznik H; Teitler M
    Eur J Pharmacol; 1992 Sep; 227(1):99-102. PubMed ID: 1330643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and structure-activity relationship of 3-Substituted benzamide, benzo [b]furan-7-carboxamide, 2,3-dihydrobenzo[b]furan-77-carboxamide, and indole-5-carboxamide derivatives as selective serotonin 5-HT4 receptor agonists.
    Kakigami T; Usui T; Tsukamoto K; Kataoka T
    Chem Pharm Bull (Tokyo); 1998 Jan; 46(1):42-52. PubMed ID: 9468636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-(Nonyloxy)tryptamine: a novel high-affinity 5-HT1D beta serotonin receptor agonist.
    Glennon RA; Hong SS; Dukat M; Teitler M; Davis K
    J Med Chem; 1994 Sep; 37(18):2828-30. PubMed ID: 8071931
    [No Abstract]   [Full Text] [Related]  

  • 15. 5-HT1D receptor agonists and human coronary artery reactivity in vitro: crossover comparisons of 5-HT and sumatriptan with rizatriptan and L-741,519.
    Longmore J; Boulanger CM; Desta B; Hill RG; Schofield WN; Taylor AA
    Br J Clin Pharmacol; 1996 Oct; 42(4):431-41. PubMed ID: 8904614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-[3-(2-Dimethylaminoethyl)-2-methyl-1H- indol-5-yl]-4-fluorobenzamide: a potent, selective, and orally active 5-HT(1F) receptor agonist potentially useful for migraine therapy.
    Xu YC; Johnson KW; Phebus LA; Cohen M; Nelson DL; Schenck K; Walker CD; Fritz JE; Kaldor SW; LeTourneau ME; Murff RE; Zgombick JM; Calligaro DO; Audia JE; Schaus JM
    J Med Chem; 2001 Nov; 44(24):4031-4. PubMed ID: 11708905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1-(2-Aminoethyl)-3-methyl-8,9-dihydropyrano[3,2-e]indole: a rotationally restricted phenolic analog of the neurotransmitter serotonin and agonist selective for serotonin (5-HT2-type) receptors.
    Macor JE; Fox CB; Johnson C; Koe BK; Lebel LA; Zorn SH
    J Med Chem; 1992 Oct; 35(20):3625-32. PubMed ID: 1433172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3,4,5-tetrahydro- and 2,3,4,5,11,11a-hexahydro-1H-[1,4]diazepino[1,7-a]indoles: new templates for 5-HT(2C) agonists.
    Ennis MD; Hoffman RL; Ghazal NB; Olson RM; Knauer CS; Chio CL; Hyslop DK; Campbell JE; Fitzgerald LW; Nichols NF; Svensson KA; McCall RB; Haber CL; Kagey ML; Dinh DM
    Bioorg Med Chem Lett; 2003 Jul; 13(14):2369-72. PubMed ID: 12824036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
    Gupta P; Butler P; Shepperson NB; McHarg A
    Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery.
    Bouchelet I; Case B; Olivier A; Hamel E
    Br J Pharmacol; 2000 Feb; 129(3):501-8. PubMed ID: 10711348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.